Earnings History Data for AnaptysBio (ANAB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AnaptysBio
AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-03-2024 | AH | ANAB | AnaptysBio | 655.00 | -1.59 | -1.74 | 0.00 | AnaptysBio GAAP EPS of -$1.59 [3/11/2024 4:52 PM] |
26.21 | 2.86 (12.25%) |
25.72 | 2.37 (10.15%) |
13.36 - 27.50 | 454,387 | 200,000 | 613 | ||
| 02-11-2023 | AH | ANAB | AnaptysBio | 433.00 | -1.41 | -1.72 | 0.00 | AnaptysBio GAAP EPS of -$1.41 beats by $0.41, revenue of $3.32M beats by $1.84M [11/2/2023 5:43 PM] |
17.50 | 1.30 (8.06%) |
16.20 | 0.0 (0.00%) |
15.88 - 32.44 | 174,432 | 230,000 | 5,793 | ||
| 07-08-2023 | AH | ANAB | AnaptysBio | 506.00 | -1.50 | -1.65 | 0.00 | AnaptysBio GAAP EPS of -$1.50 beats by $0.20, revenue of $3.46M beats by $0.69M [8/7/2023 5:14 PM] |
18.93 | 0.47 (2.55%) |
19.00 | 0.54 (2.93%) |
16.66 - 32.44 | 2,038,930 | 210,000 | 2,917 | ||
| 01-03-2023 | AH | 4:05 PM ET (Mar 1) |
ANAB | AnaptysBio | 699.00 | -0.93 | -0.92 | 0.00 | AnaptysBio GAAP EPS of -$0.93, revenue of $6.8M [3/1/2023 5:39 PM] |
24.73 | -0.41 (-1.63%) |
25.14 | 0.0 (0.00%) |
18.20 - 32.44 | 193,157 | 220,000 | 1,660 | |
| 08-11-2022 | AH | 4:05 PM ET (Nov 8) |
ANAB | AnaptysBio | 838.00 | -1.18 | -0.47 | 0.00 | AnaptysBio GAAP EPS of -$1.18 misses by $0.56, revenue of $1.29M misses by $12.14M [11/8/2022 4:59 PM] |
29.43 | -0.14 (-0.47%) |
29.14 | -0.43 (-1.45%) |
18.20 - 37.40 | 86,370 | 180,000 | 4,227 | |
| 04-05-2022 | AH | After the close (May 4) |
ANAB | AnaptysBio, Inc. | 647.53 | -1.31 | -0.87 | -0.66 | AnaptysBio GAAP EPS of -$1.31 misses by $0.32, revenue of $0.97M misses by $4.08M [5/4/2022 5:41 PM] |
21.60 | -2.73 (-11.22%) |
23.93 | -0.40 (-1.64%) |
20.56 - 37.89 | 313,190 | 350,000 | 3,301 | |
| 07-03-2022 | PM | Before the open (Mar 7) |
ANAB | AnaptysBio | 828.00 | -1.13 | 2.28 | 0.00 | 29.58 | -0.67 (-2.21%) |
29.78 | -0.47 (-1.55%) |
17.72 - 37.89 | 29,508 | 130,000 | 900 | ||
| 04-11-2021 | AH | 4:05 PM ET (Nov 4) |
ANAB | AnaptysBio, Inc. | 878.42 | -0.24 | -0.74 | -0.87 | AnaptysBio EPS beats by $0.64, beats on revenue [11/4/2021 5:08 PM] |
37.06 | 2.57 (7.45%) |
34.49 | 0.0 (0.00%) |
17.72 - 37.63 | 233,858 | 220,000 | 1,218 | |
| 04-05-2021 | AH | 4:05 PM ET (May 4) |
ANAB | Anaptysbio, Inc. | 639.00 | -0.66 | -0.71 | 0.00 | AnaptysBio EPS beats by $0.03, beats on revenue [5/4/2021 5:12 PM] |
24.48 | 0.98 (4.17%) |
24.10 | 0.60 (2.55%) |
13.92 - 35.85 | 309,080 | 260,000 | 1,129 | |